Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P20366 (substance P)
 21,176 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Experimental guinea pigs with allergic rhinitis were treated with capsaicin (CAP). During the whole course of treatment, nasal secretions, sneezing and nasal scratching were observed and recorded, as compared quantitatively with those of the control group. By means of specific radioimmunoassay, determination of the amount of substance P (SP) in the nasal mucosa was done in the treated group, untreated group and normal control group. By using the filter paper technique, the functional status of the nasal secretion was observed. The experimental group was given CAP by dripping into the nasal cavities for 15 days. The results indicated that the various symptoms of allergic rhinitis were obviously relieved. The nasal secretions were decreased by 64% as compared with those before the treatment; and SP content in the nasal mucosa was remarkably reduced in comparison with untreated group. The results of the experiment indicated: the repeated use of CAP might effectively deplete SP content in the nasal mucosa and prove the new theory of the effects of CAP on the desensitization of the SP nerves. CAP as a blocking agent of SP nerves blocked the axon reflex and exerted curative effect on allergic rhinitis.
 ...
PMID:[Experimental study on blocking agent of substance P nerves in the treatment of allergic rhinitis]. 753 31

By using the supersensitive and highly specific SP-radioimmunoassays to measure the concentration of substance P (SP) in the plasma of patients with allergic rhinitis, the authors found that the levels of SP in the plasma had significantly increased as compared with normal controls (P < 0.001). Using the laser-Doppler flowmeter to measure the blood flow in the nasal mucosa, it was also found that the increase in blood flow in the nasal mucosa had a close correlation with the content of SP. The results show that SP could induce vasodilation in nasal mucosa, lead to a significant increase in nasal blood flow. The pathogenetic importance of the neuropeptide SP in allergic rhinitis and the clinical significance of changes in SP in the plasma of subjects with allergic rhinitis has been discussed.
 ...
PMID:[Substance P in plasma of patients with allergic rhinitis and its clinical significance]. 769 2

Research work over the last ten years has identified a nonadrenergic, non cholinergic innervation in the upper and lower airways, in man and other animals. This innervation has two components: An excitatory bronchoconstrictor component, of which the neurotransmitters are peptides, substance P, neurokinin A, CGRP and gastrin-releasing peptide. A bronchodilating component known as inhibitor, of which the neurotransmitters are the vasoactive intestinal peptide and nitric oxide. Those neurotransmitters effect all the systems that are involved in allergic respiratory diseases, asthma and allergic rhinitis. They may therefore have a role to play in the physiopathology of these diseases.
 ...
PMID:[Airway neuropeptides--what is their role in physiopathology?]. 774 59

This paper reported the clinical effects and therapeutic mechanism of blocking agent of substance P(SP) nerves on prerennial allergic rhinitis. We applied capsaicin (CAP) in the treatment of 50 cases of perennial allergic rhinitis once a week and 4 times as a therapeutic course. By using highly specific and highly sensitive SP radioimmunoassay, the SP contents in nasal secretions were determined before and after CAP therapy. The results showed that clinical symptoms of allergic rhinitis were obviously relieved and SP content in the nasal secretions was remarkably reduced from 29.444 +/- 14.280pmol/L before CAP therapy to 16.848 +/- 10.622 pmol/L after therapy (P < 0.001). Of the 50 cases, 35 cases (70.0%) showed the best effects, 12 cases (24.0%) better effects and 3 cases (6.0%) no effects. The total effective rate was 94.0%. The study indicated that therapeutic mechanism of CAP on perennial allergic rhinitis is related to the reducing of SP and the blocking of axonal reflex of the SP nerves.
 ...
PMID:[Clinical observation and therapeutic mechanism of blocking agent of substance P nerves in the treatment of perennial allergic rhinitis]. 857 75

An immunohistochemical study was made on the distribution of neuropeptides in 36 surgical specimens of the inferior nasal turbinate mucosa obtained from 32 patients with allergic rhinitis. Eleven patients (15 specimens) of the 32 underwent chemosurgery in which trichloracetic acid (TCA) was used before excision. In these patients a watery nasal discharge remained even after TCA application, although the nasal obstruction decreased. As a control, 6 specimens obtained from 6 patients with non-allergic rhinitis were also studied. In the present study, the distribution of Substance P (SP) was examined as an index of the parasympathetic nervous system. The distribution of nerve fibers showing a positive reaction specific to each of the two types of neuropeptides was examined in the frontal sections of the specimens at distances of 5 and 15 mm from the anterior tip of the inferior turbinate. In particular, the modes of the distribution in the superficial and deep layers of the mucosa were compared. It was found that, in the patients with allergic rhinitis who had not undergone TCA treatment, both SP-positive and VIP-positive fibers were abundant in the anterior portion of the turbinate immediately beneath the basement membrane. In those patients who underwent chemosurgery prior to excision, SP-positive fibers were very scarce in both superficial and deep layers, whereas VIP-positive fibers appeared to exist only in the deep layer around the remaining nasal glands. In the specimens obtained from patients with non-allergic rhinitis, there was no appreciable difference in the pattern of distribution of SP-and VIP-positive fibers among different sites of the specimens. The present study would indicate that chemosurgery using TCA inhibited the appearance of neuropeptides and resulted in improvement in clinical symptoms. However, in those patients having a continuous watery discharge even after TCA treatment, the function of the remaining nasal glands might be responsible for the symptom, although the contribution of VIP to the increase in vasopermeability should also be taken into consideration. Further studies are needed to determine the distribution of neuropeptides around the vessel walls.
 ...
PMID:[Distribution of neuropeptides in the inferior nasal turbinate mucosa of patients with allergic rhinitis]. 868 63

Ragweed (Ambrosia artemisiifolia), the major cause of late summer hay fever (allergic rhinitis) in the United States and Canada, is clinically the most important source of the seasonal aeroallergens. A novel endopeptidase was extracted from the pollen of this plant and purified by a series of column chromatographic steps. It has a molecular mass of 82 kDa according to gel filtration and SDS-polyacrylamide gel electrophoresis and a pH optimum near 9.0, and its activity is unaffected by chelating or reducing agents. A 17-amino acid amino-terminal sequence of this protein showed no similarity with any other proteases. The enzyme was inhibited by diisopropyl fluorophosphate, a general serine class inhibitor, and more specifically N-p-tosyl-L-phenylalanine chloromethyl ketone, a chymotrypsin-like proteinase inhibitor. Various synthetic substrates were efficiently cleaved with a strong preference for Phe in the P1 and P3 position and Pro in the P2 position. This specificity was confirmed through inhibition studies with both peptidyl chloromethyl ketone and organophosphate inhibitors. In addition to synthetic substrates, the neuropeptides, vasoactive intestinal peptide and substance P, which are required for normalized lung functions, were also rapidly hydrolyzed. Activity toward protein substrates was not detected with the exception of the inactivation of alpha-1-proteinase inhibitor, which occurred through cleavage within the reactive site loop. These results indicate that the purified enzyme is a novel endopeptidase, which may be involved in both the degradation of neuropeptides and the inactivation of protective proteinase inhibitors during pollen-initiated allergic reactions.
 ...
PMID:Purification and characterization of a novel endopeptidase in ragweed (Ambrosia artemisiifolia) pollen. 882 72

We have investigated the nasal response to substance P after pollen exposure in seasonal allergic rhinitic patients. Seven patients with strictly seasonal allergic rhinitis were studied during the pollen season, 24 h after nasal challenge with pollen. They received increasing doses of nebulized substance P (0 to 80 nmol) in each nostril. Responses were assessed by measurement of nasal airway resistance by posterior rhinomanometry and quantification of albumin, histamine, and inflammatory cells in the nasal lavage fluid. Nasal airway resistance increased in a dose-dependent manner after substance P challenge. Protein and albumin in nasal lavage fluids increased after administration of substance P: from 2.6 +/- 0.3 to 6.8 +/- 1.1 mg for protein (P < 0.01) and from 0.2 +/- 0.1 to 3.1 +/- 0.6 mg for albumin (P < 0.02). Expressed as a percentage of total protein, albumin increased from 10.5 +/- 3.6% to 39.9 +/- 3.5% (P < 0.02), suggesting occurrence of plasma leakage. No histamine release was observed after challenge with substance P. Total cell counts significantly increased from 11.4 +/- 2.4 to 41.8 +/- 17.3 x 10(3) cells/ml after substance P (P < 0.05). Eosinophils were already numerous before substance P challenge (2.1 +/- 0.7 x 10(3) cells/ml), and the number of eosinophils markedly increased in all patients after substance P (for the whole group, 25.8 +/- 13.3 cells/ml, P < 0.05). In contrast, the number of neutrophils only slightly increased in five patients, and changes did not reach significance for the group as a whole. Our results show that substance P induces nasal obstruction and albumin extrusion in allergic rhinitic patients after repeated pollen exposure. These vascular phenomena are associated with recruitment of eosinophils. Since substance P is known to be released after nasal allergen challenge, our data suggest a role for substance P in the chronic eosinophilic inflammation of the nasal mucosa observed in symptomatic allergic rhinitis.
 ...
PMID:Selective recruitment of eosinophils by substance P after repeated allergen exposure in allergic rhinitis. 883 26

This study aims to investigate the roles of neuropeptides in the pathophysiology of human nasal diseases. By using immunohistochemistry and radioimmunoassay, we detected the presence, distribution and concentrations of the following neuropeptides in human nasal tissue: vasoactive intestinal peptides (VIP), neuropeptide Y (NPY), substance P (SP), and calcitonin gene-related peptides (CGRP). This was performed in human nasal inferior turbinate mucosa from 20 patients with allergic rhinitis, twenty-five patients with chronic hypertrophic rhinitis and 10 patients without any nasal disease conditions. The presence and distribution of NPY. CGRP and SP fibers among the three subject groups displayed no evident differences. VIP fibers were densely stained around the vessels in the allergic group. In contrast, these fibers were more prominently distributed around the submucosal glands of the chronic hypertrophic rhinitis group. The concentration of VIP and SP in human nasal inferior turbinate showed a significant increase in allergic subjects. Thus, VIP may be revelant to the hypertrophic changes of the nasal mucosa. Both SP and VIP may play significant neuroimmunological roles in the pathogenesis of allergic rhinitis.
 ...
PMID:Neuropeptidergic innervation of human nasal mucosa in various pathological conditions. 920 81

This study was performed to test the hypothesis that activated eosinophils or their secretory products can directly stimulate sensory neurons to release their neuropeptides. Neurons derived from neonatal rat dorsal root ganglia (DRG), which synthesize and store sensory neuropeptides, were placed in primary cell culture and were exposed to eosinophils or their bioactive mediators. The resultant release of substance P (SP) was measured by enzyme-linked immunosorbent assay and was expressed as a percent (mean +/- SE) of total neuronal SP content. Eosinophils were isolated from human volunteers with a history of allergic rhinitis and/or mild asthma and were activated by incubation with cytochalasin B (5 micrograms/ml) and N-formyl-methionyl-leucyl-phenylalanine (FMLP, 1 microM). Activated eosinophils [6 x 10(6)/ml, suspended in Hanks' buffered salt solution (HBSS)] applied to cultured DRG neurons for 30 min increased basal SP release 2.4-fold compared with HBSS-exposed neurons (activated eosinophils 11.10 +/- 2.48% vs. HBSS 4.59 +/- 0.99%; P = 0.002), whereas neither nonactivated eosinophils nor cytochalasin B and FMLP in HBSS influenced SP release. Additional cultured DRG neurons were exposed to soluble products made by eosinophils. Compared with SP release under control conditions (2.37 +/- 0.34%), major basic protein (MBP) increased release in a concentration-related fashion (e.g., 3 microM MBP: 6.23 +/- 0.67%, P = 0.006 vs. control), whereas neither eosinophil cationic protein (3 microM), eosinophil-derived neurotoxin (3 microM), leukotriene D4 (500 nM), platelet-activating factor (100 nM), nor H2O2 (100 microM) affected SP release. These studies demonstrate that activated eosinophils can stimulate cultured DRG neurons directly and suggest that MBP may be the responsible mediator.
 ...
PMID:Activated eosinophils elicit substance P release from cultured dorsal root ganglion neurons. 937 40

To study the density alterations of three peptidergic terminals in nasal mucosa of allergic rhinitis (AR), an exhaustive immunohistochemical sutdy on the changes of substance P (SP), neurokinin A (NKA) and neurokinin B (NKB) in nasal mucosa was carried out in a toluene-2, 4-isocyanate (TDI)-induced rat AR model. The densities of all three tachykininergic terminals in nasal mucosa were significantly increased (P < 0.01) in experimental group as compared with control group. Increased staining, thickening of peptidergic terminals as well as enlargement of varicosities were observed. The increased densities of three tachykininergic terminals (SP, NKA and NKB) in nasal mucosa in rat AR model indicates that tachykinins play an important role in the pathogenesis of AR.
 ...
PMID:[Immunohistochemical study on three peptidergic terminals in nasal mucosa in a rat AR model]. 964 48


<< Previous 1 2 3 4 5 Next >>